Prisca Boisguerin

Title: Prisca Boisguerin: Innovator in Apoptosis Research

Introduction

Prisca Boisguerin is a notable inventor based in Le Grand-du-Roi, France. She has made significant contributions to the field of apoptosis research, particularly through her innovative patent related to the inhibition of cell apoptosis. Her work has implications for the treatment and prevention of various diseases associated with apoptosis.

Latest Patents

Prisca Boisguerin holds a patent titled "Inhibitors of apoptosis and uses thereof." This invention focuses on fragments of the Death-Domain Associated protein (DAXX protein) and the Fas-Associated Death Domain protein (FADD protein) that inhibit cell apoptosis, especially apoptosis mediated by the Fas receptor. The patent also covers derivatives of these anti-apoptotic fragments, conjugates, and pharmaceutical compositions that utilize these fragments. The medical applications of her work are crucial for addressing diseases and conditions linked to apoptosis.

Career Highlights

Throughout her career, Boisguerin has worked with esteemed institutions such as the Centre National de la Recherche Scientifique and Université Montpellier 2 - Sciences et Techniques. Her research has been pivotal in advancing our understanding of apoptosis and its implications in medical science.

Collaborations

Some of her notable coworkers include Stéphanie Barrere and Joël Nargeot, who have contributed to her research endeavors.

Conclusion

Prisca Boisguerin's innovative work in apoptosis research highlights her role as a significant inventor in the scientific community. Her contributions continue to influence the development of therapeutic strategies for diseases related to cell apoptosis.